MiNK Therapeutics
INKT
29 hedge funds and large institutions have $848K invested in MiNK Therapeutics in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.
0.01% less ownership
Funds ownership: 0.27% → 0.26% (-0.01%)
0% less capital invested
Capital invested by funds: $848K → $848K (-$278)
12% less funds holding
Funds holding: 33 → 29 (-4)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$22K |
| 2 |
BlackRock
New York
|
+$10.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.29K |
| 4 |
Goldman Sachs
New York
|
+$1.88K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$496 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$18.9K |
| 3 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$18.1K |
| 4 |
Millennium Management
New York
|
-$6.79K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $102 | – | – | – |
|
|
KFI
27
Key Financial Inc
West Chester,
Pennsylvania
| $41 | – | – | – |
|
|
HIA
28
Harbor Investment Advisory
Lutherville,
Maryland
| $5 | – | – | – |
|
|
AF
29
Allworth Financial
Folsom,
California
| $2 | – | – | – |
|
30
AssetMark Inc
Concord,
California
| $1 | – | – | – |
|
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$27.1K | -2,983 | Closed |
|
|
32
Citadel Advisors
Miami,
Florida
| – | -$18.9K | -2,081 | Closed |
|
|
AG
33
Artal Group
Luxembourg
| – | -$1.74K | -192 | Closed |
|
|
SN
34
Sittner & Nelson
Eugene,
Oregon
| – | -$53 | -6 | Closed |
|
35
RhumbLine Advisers
Boston,
Massachusetts
| – | -$43 | -5 | Closed |
|
|
LF
36
LifeSteps Financial
Claremont,
California
| – | -$25 | -3 | Closed |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$39 | +4 | +33% |
|
INKT Hedge Fund Activity: Q2 2024 in Review
29 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in MiNK Therapeutics (INKT) for Q2 2024, worth a combined $848K — down 0.03% from $848K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of INKT and 2 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $22K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $27.1K sold.
- 29 institutional investors held MiNK Therapeutics (INKT) as of Q2 2024, down from 33 in Q1 2024.
- Funds reported $848K of MiNK Therapeutics stock for Q2 2024, down 0.03% quarter-over-quarter.
- 2 funds opened new MiNK Therapeutics positions in Q2 2024 and 6 closed out, a net change of -4 holders.
- The largest MiNK Therapeutics buyer in Q2 2024 was Renaissance Technologies, an estimated $22K added.
- The largest MiNK Therapeutics seller in Q2 2024 was Susquehanna International Group, an estimated $27.1K sold.
Based on aggregated 13F filings for Q2 2024.